jeudi 9 avril 2015

Onco Actu du 9 avril 2015


Les étoiles de couleur jaune signalent des articles dont la lecture est en priorité suggérée (1*) ou recommandée (3*).

1. Biologie

Researchers identify subtype of lethal prostate cancer [SUNY Upstate Medical University]

Biologists identify brain tumor weakness [MIT News]

2.5 Etiologie - Gènes

For cancer risk, some BRCA mutations are more dangerous than others [LA Times]

2.8 Etiologie - Contraceptifs, THS

No strong association between lung cancer risk in women and reproductive history or hormone use [IASLC]

3.1 Tabac

U.S. appeals court deals setback to Florida tobacco plaintiffs [Reuters]

4.9 Dép., diag. & prono. - Sein

Breast cancer risk test devised in 77-gene analysis [BBC News]

Genetic screening could improve breast cancer prevention [The Institute of Cancer Research]

5. Traitements

Cancer treatment gets more personalised than ever [PHG Foundation]

Doctors Test Tumor Paint In People [NPR]

Too Many Favorable Clinical Trials? Maybe Not [In the Pipeline]

5.2 Pharma

A CEO's View On Cancer, Virus-Based 'Cures,' And '60 Minutes' Vs. Reality [Forbes]

UK biotech Silence Therapeutics raises $58 million for its RNA drive [Reuters]

5.2.1 Pharma - Partenariats

Advaxis and Merck Announce Initiation of Enrollment in the Phase 1/2 Study of ADXS-PSA in Combination with Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for the Treatment of Advanced Prostate Cancer [Merck]

5.3 Traitements - FDA, EMA,...

Promoting high quality scientific research in paediatric medicines [EMA]

5.4 Traitements - Economie

Price of cancer drugs varies widely based on who’s paying [UNC News]

6.6 Publications

ORCID Receives a $3 Million Grant to Build International Engagement Capacity [ORCID]

6.8 Communication

Film Succeeds in Relaying the Complexity and Hope of Cancer Treatment [CANCER RESEARCH Catalyst]